Medications for Diabetes Mellitus Noninsulindependent

16 results
  • brenzavvy

    (Bexagliflozin)
    TheracosBio, LLC
    BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.
  • cycloset

    (bromocriptine mesylate)
    Santarus, Inc.
    CYCLOSET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not for use in type 1 diabetes or diabetic ketoacidosis, and its efficacy is limited with certain other medications.
  • invokamet

    (canagliflozin and metformin hydrochloride)
    Janssen Pharmaceuticals, Inc.
    INVOKAMET and INVOKAMET XR are indicated as adjuncts to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus. Canagliflozin component reduces risks of major cardiovascular events and kidney disease in specific patient populations.
  • janumet

    (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
    Merck Sharp & Dohme LLC
    JANUMET is indicated for improving glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.
  • janumet

    (sitagliptin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    JANUMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes or those with a history of pancreatitis.
  • januvia

    (sitagliptin)
    Merck Sharp & Dohme LLC
    JANUVIA® is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.
  • jardiance

    (Empagliflozin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    JARDIANCE is indicated for reducing the risk of cardiovascular death and hospitalization in adults with heart failure, chronic kidney disease, and type 2 diabetes with established cardiovascular disease. It also aids glycemic control as an adjunct to diet and exercise in patients aged 10 and older with type 2 diabetes.
  • mounjaro

    (tirzepatide)
    Eli Lilly and Company
    MOUNJARO® is indicated as an adjunct to diet and exercise to enhance glycemic control in adults with type 2 diabetes mellitus. It is not studied in patients with pancreatitis and is not indicated for type 1 diabetes mellitus.
  • onglyza

    (SAXAGLIPTIN)
    AstraZeneca Pharmaceuticals LP
    ONGLYZA is indicated for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, both as monotherapy and in combination with other medications.
  • rybelsus

    (Oral Semaglutide)
    Novo Nordisk
    RYBELSUS is indicated for improving glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise. It is not recommended for patients with type 1 diabetes mellitus.